Public Employees Retirement System of Ohio Makes New $1.77 Million Investment in Tempus AI, Inc. $TEM

Public Employees Retirement System of Ohio bought a new position in Tempus AI, Inc. (NASDAQ:TEM) in the 2nd quarter, Holdings Channel.com reports. The firm bought 30,639 shares of the company’s stock, valued at approximately $1,775,000.

A number of other institutional investors and hedge funds have also bought and sold shares of TEM. JPL Wealth Management LLC bought a new position in shares of Tempus AI during the 3rd quarter valued at $26,000. Los Angeles Capital Management LLC purchased a new position in Tempus AI during the 4th quarter valued at about $27,000. Harvest Fund Management Co. Ltd bought a new position in Tempus AI in the 3rd quarter worth $38,000. Whittier Trust Co. raised its position in shares of Tempus AI by 190.0% in the 1st quarter. Whittier Trust Co. now owns 870 shares of the company’s stock worth $41,000 after acquiring an additional 570 shares in the last quarter. Finally, EverSource Wealth Advisors LLC increased its stake in shares of Tempus AI by 88.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 691 shares of the company’s stock worth $44,000 after acquiring an additional 325 shares in the last quarter. 24.22% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

TEM has been the subject of a number of recent research reports. Weiss Ratings cut Tempus AI from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, August 27th. Lake Street Capital cut shares of Tempus AI to a “hold” rating in a report on Monday, July 20th. Stifel Nicolaus dropped their target price on Tempus AI from $60.00 to $50.00 and set a “hold” rating on the stock in a research report on Monday, August 3rd. Freedom Capital raised shares of Tempus AI to a “hold” rating in a research report on Tuesday, June 30th. Finally, Piper Sandler upgraded Tempus AI from a “neutral” rating to an “overweight” rating and boosted their price objective for the company from $56.00 to $76.00 in a research note on Tuesday, September 1st. Eleven analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $68.93.

Tempus AI Stock Performance

Shares of TEM stock opened at $64.62 on Monday. The stock’s 50 day simple moving average is $55.77 and its two-hundred day simple moving average is $52.13. Tempus AI, Inc. has a 1 year low of $40.77 and a 1 year high of $104.32. The company has a market cap of $11.66 billion, a PE ratio of -44.87 and a beta of 3.72. The company has a debt-to-equity ratio of 3.06, a current ratio of 3.30 and a quick ratio of 3.16.

Tempus AI (NASDAQ:TEM) last posted its quarterly earnings data on Thursday, July 30th. The company reported ($0.04) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.10. Tempus AI had a negative net margin of 17.77% and a negative return on equity of 50.28%. The company had revenue of $382.49 million for the quarter, compared to analyst estimates of $379.69 million. During the same period in the prior year, the company posted ($0.22) EPS. The firm’s revenue for the quarter was up 21.6% on a year-over-year basis. Research analysts predict that Tempus AI, Inc. will post -1.38 earnings per share for the current year.

Insiders Place Their Bets

In other Tempus AI news, Director Nadja West sold 3,000 shares of the firm’s stock in a transaction dated Friday, August 28th. The shares were sold at an average price of $69.00, for a total transaction of $207,000.00. Following the transaction, the director owned 31,981 shares of the company’s stock, valued at approximately $2,206,689. This trade represents a 8.58% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO James Rogers sold 26,313 shares of the business’s stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $60.00, for a total value of $1,578,780.00. Following the completion of the transaction, the chief financial officer directly owned 106,024 shares of the company’s stock, valued at approximately $6,361,440. The trade was a 19.88% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders sold 1,043,988 shares of company stock worth $56,963,417. 24.26% of the stock is owned by company insiders.

Tempus AI Company Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.